Tamanaco Foods
0803.678.949 · rovalta.com · 26/09/2026
ACTIVE
Tamanaco Foods
Financial year 2025 · Closed on 31/12/2025
Net result-10,8 k €+84,1 %over 1 year
Gross margin-9,7 k €-113,1 %over 1 year
Equity-63,6 k €-20,4 %over 1 year
Overview
Identity
Source · BCE/KBOTamanaco Foods is a Private limited company incorporated in 2023. Its registered office is in Mechelen.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0803.678.949
- Incorporation
- 06/07/2023
- Legal form
- Private limited company
- Registered office
- Kardinaal Mercierplein 2
2800 Mechelen · FlandreSee on map - Contributed capital
- 15 000,00 €
- Latest accounts
- 31/12/2025
Signals
Healthy social debts
Financials
Source · NBB, 2 filingsTrend over 2 financial years
| 2025 | 2024 | ||
|---|---|---|---|
| Income statement | |||
| Gross margin | -9,7 k € | -113% | -4,5 k € |
| EBITDA | -7,1 k € | +88.9% | -64,2 k € |
| Operating result | -7,1 k € | +88.9% | -64,2 k € |
| Net result | -10,8 k € | +84.1% | -67,8 k € |
| Balance sheet | |||
| Equity | -63,6 k € | -20.4% | -52,8 k € |
| Total assets | – | 403,8 € | |
| Cash | – | 113,8 € | |
| Debts | 63,6 k € | +19.5% | 53,2 k € |
Board of directors
Source · NBB, accounts to 31/12/2025Other companies at this address
Kardinaal Mercierplein 2 2800 Mechelen| Company | CBE no. |
|---|---|
| 1025.942.868 | |
ALL IN ONE DELIVERY● Bankrupt | 0691.693.043 |
Amber Therapeutics Belgium● Active | 1042.186.806 |
Anima● Active | 0696.648.852 |
ANIRES● Active | 1016.204.761 |
AVENO CARGO CENTER● Active | 0648.895.257 |
| 0802.924.725 | |
BENELUX & PARTNERS● Active | 0764.941.208 |
BlueStone Underwriting● Active | 1042.777.516 |
C&A ELECTRICITY● Bankrupt | 0797.043.258 |
CaptureAge● Active | 0734.747.383 |
CHARMEWONING● Bankrupt | 0826.369.328 |
Cybercontract● Active | 0557.948.651 |
Delgabre Group● Bankrupt | 0739.758.919 |
ESKENS BENELUX● Active | 0439.773.650 |
Foundation CaptureAge● Active | 1015.127.269 |
FRUTAROM BELGIUM● Active | 0403.593.145 |
HANOVER DISPLAYS● Active | 0737.945.118 |
HERA● Active | 0441.391.273 |
ICON Clinical Research Belgium● Active | 0467.032.927 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | |
|---|---|---|
| Type of account | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 06/07/2023 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 |
| Length of the financial year | 12 months | 18 months |
| Filing date | 08/07/2026 | 25/07/2025 |
| General meeting | 24/06/2026 | 30/06/2025 |
| Currency of the financial year | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 2 filingsValuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/2025Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other10/07/2023RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-10,8 k €↑
- 2024Annual accounts 2024-67,8 k €
- 06/07/2023IncorporationPrivate limited company